Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Nonalcoholic Fatty Liver Patients

A study in the July issue of CGH compares the colonic microbiome and volatile organic compound metabolome of obese nonalcoholic fatty liver disease patients with that of healthy-weight individuals. Dr. Kuemmerle speaks to author Dr. Kevin P. Rioux.

Source: Clinical Gastroenterology and Hepatology - July 5, 2013 Category: Gastroenterology Authors: AGA Source Type: podcasts